Back to search

Boston University

Evaluation of fibrosis and anti-fibrotic therapeutics in systemic sclerosis

Abstract

dc:description.abstract

Systemic sclerosis (SSc) is a complex yet elusive connective tissue disease where vascular, immune, and fibrotic alterations occur. Nearly all organ systems are affected, leading to significant impacts on patients’ quality of life. A literature review was conducted to assess SSc pathogenesis and treatment options, focusing on diffuse cutaneous SSc. Vasculopathy and immune dysregulation culminate in the activation of fibroblasts into myofibroblasts. Fibrosis is the most lethal complication of SSc and is characterized by overaccumulation of extracellular matrix. Pathophysiology of skin fibrosis and lung fibrosis—comprising Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease (ILD)—was examined. Fibrotic entities are generally conserved across phenotypes of fibrosis, yet some significant differences exist among the different patterns. Progressive ILD is the leading cause of death in SSc. There is an established association between decline in forced vital capacity and mortality. Though many current therapies target organ-related complications of SSc, treatments targeting fibrosis are limited. At present, there is no disease-modifying therapy for SSc. Therapies inhibiting fibrotic mechanisms were evaluated and were concluded to show promise for the treatment of SSc.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Alagar, Indrani
Advisor dc:contributor.advisor
  • Offner, Gwynneth
ORCID dc:identifier.orcid

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51414

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Alagar, Indrani. Evaluation of fibrosis and anti-fibrotic therapeutics in systemic sclerosis. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/51414